MorGene devotes to develop innovative tools for Genomics research and to enable development of in intro diagnostics devices based on sequencing technologies. Enabled by our first proprietary multiplex-PCR-based targeted resequencing technology, GenSeizer, and our comprehensive data analysis platform, we are exploring applicaitons in antimicrobial mangament.
Company Details
- Founded
- -
- Address
- Bld 5, 1180 Xing Xian Road, Shanghai,shanghai 200000,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.morgene.net/
- Keywords
- IVD Development, Antimicrobial Managment, Multiplex PCR Solution, Sequencing Data Analysis, Comprehensive Data Management, Targeted Sequencing.
- HQ
- Shanghai, Shanghai
Morgene Biotech | 茂槿生物 Questions
Morgene Biotech | 茂槿生物's website is http://www.morgene.net/
Morgene Biotech | 茂槿生物's LinkedIn profile is https://cn.linkedin.com/company/morgene-biotech
Morgene Biotech | 茂槿生物's industry is
Biotechnology Research
Morgene Biotech | 茂槿生物's top competitors are
Global Founders Capital,
Amsa - Asset Management Study Association,
Cantor Fitzgerald Asset Management,
Aurelius,
Valpre Capital.
Morgene Biotech | 茂槿生物's categories are Biotechnology Research
Morgene Biotech | 茂槿生物's founding year is 2015
